|
Market Closed -
Nasdaq
04:00:00 02/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 125.01 USD | +1.45% |
|
-3.63% | +26.57% |
| 09-01 | Incyte Corporation Enters Agreement with U.S. Centers for Medicare & Medicaid Services | CI |
| 08-29 | US FDA approves Takeda, Protagonist's drug for rare blood cancer | RE |
| Market Cap | 25.34B 21.86B 20.56B 18.73B 35.22B 2,405B 35.41B 243B 94.61B 1,223B 95.14B 93.07B 4,056B | P/E 2026 * |
55.8x | P/E 2027 * | 17.3x |
|---|---|---|---|---|---|
| Enterprise Value | 21.11B 18.21B 17.13B 15.6B 29.34B 2,003B 29.5B 202B 78.81B 1,019B 79.26B 77.54B 3,379B | EV / Sales 2026 * |
3.55x | EV / Sales 2027 * | 3.09x |
| Free-Float |
98.16% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Incyte Corporation
| 1 day | +1.45% | ||
| 1 week | -3.63% | ||
| Current month | +1.45% | ||
| 1 month | +4.59% | ||
| 3 months | +30.78% | ||
| 6 months | +23.44% | ||
| Current year | +26.57% |
| 1 week | 121.61 |  | 128.2 |
| 1 month | 115.77 | | 130.8 |
| Current year | 89.25 | | 132.6 |
| 1 year | 81.09 | | 132.6 |
| 3 years | 50.27 | | 132.6 |
| 5 years | 50.27 | | 132.6 |
| 10 years | 50.27 | | 153.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Meury
CEO | Chief Executive Officer | 58 | 26/06/2025 |
Suketu Upadhyay
DFI | Director of Finance/CFO | 57 | 04/05/2026 |
Pablo Cagnoni
PSD | President | 62 | 05/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Julian Baker
CHM | Chairman | 59 | 26/06/2025 |
| Director/Board Member | 72 | 20/01/2015 | |
Paul Clancy
BRD | Director/Board Member | 64 | 20/01/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 25/8/26 | Tax | EVP, Human Resources | -504 | 0.0002% | ||
| 19/8/26 | Sell | Chairperson | -10,801 | 0.0053% | ||
| 12/8/26 | Sell | Chairperson | -10,803 | 0.0053% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.45% | -3.63% | +47.75% | +93.24% | 24.98B | |
| +3.10% | -1.17% | +41.87% | -0.94% | 79.79B | |
| +0.05% | +0.01% | -17.23% | -35.75% | 58.85B | |
| +9.93% | -2.87% | +540.39% | +37.06% | 56.03B | |
| +0.13% | -4.10% | -0.74% | +34.87% | 51.26B | |
| +1.49% | -2.50% | +9.69% | +163.06% | 47.68B | |
| -0.28% | -2.14% | +63.39% | -19.14% | 32.01B | |
| -2.12% | +1.50% | -3.61% | +189.46% | 23.05B | |
| +1.69% | -2.60% | +61.63% | +116.78% | 16.31B | |
| -2.11% | -1.47% | -14.00% | +794.40% | 15.64B | |
| Average | +1.34% | -1.39% | +72.91% | +137.30% | 40.56B | |
| Weighted average by Cap. | +2.12% | -1.56% | +91.11% | +73.64% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.94B 5.13B 4.82B 4.39B 8.26B 564B 8.3B 57B 22.18B 287B 22.31B 21.83B 951B | 6.27B 5.4B 5.08B 4.63B 8.71B 595B 8.76B 60.1B 23.39B 302B 23.52B 23.01B 1,003B |
| Net income | 466M 402M 378M 344M 648M 44.21B 651M 4.47B 1.74B 22.49B 1.75B 1.71B 74.57B | 1.5B 1.29B 1.21B 1.11B 2.08B 142B 2.09B 14.35B 5.58B 72.22B 5.62B 5.49B 239B |
| Net Debt | -4.23B -3.65B -3.43B -3.13B -5.88B -401B -5.91B -40.57B -15.79B -204B -15.88B -15.54B -677B | -5.99B -5.17B -4.86B -4.43B -8.33B -569B -8.37B -57.47B -22.37B -289B -22.49B -22.01B -959B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/09/26 | US$125.01 | +1.45% | 1,191,895 |
| 31/08/26 | US$123.22 | -0.92% | 1,483,195 |
| 28/08/26 | US$124.37 | -2.64% | 1,215,069 |
| 27/08/26 | US$127.74 | -0.30% | 700,682 |
| 26/08/26 | US$128.12 | -1.23% | 800,283 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- INCY Stock
Select your edition
All financial news and data tailored to specific country editions
